Automated cell separation with autoMACS NEO Separator
23 Apr 2024
The autoMACS® NEO Separator sets a new benchmark for automated cell separation. Its fast and gentle isolation of any cell type makes it ideal for diverse downstream applications, such as flow cytometry, functional assays, or omics studies. It features automated priming for prescheduled wake-up, an experiment planner for intuitive setup of automated cell separation, a barcode reader for quickly entering reagents by scanning vials, and optimized programs to choose between high purity or high recovery.
About the company

Miltenyi Biotec B.V. & Co. KG
At Miltenyi Biotec, we’re committed to empowering scientific discovery and impacting human lives. For more than 25 years, our work has played an essential role in the biomedical research and cellular therapy community. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our integrated technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. This complete portfolio enables the access, analysis, and utilization of primary and primary-derived cells. Our expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. Today, Miltenyi Biotec has more than 1,300 employees in 22 countries.




